Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial

Osteopontin – A multi-modal marker and mediator in atherosclerotic vascular disease

(2014) Talya Wolak   ATHEROSCLEROSIS

A comparison of maternal mortality estimates from GBD 2013 and WHO

(2014) Nicholas J Kassebaum et al.   LANCET

High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention

(2013) Mette Bjerre et al.   European Journal of Preventive Cardiology

Analysis of Osteopontin Levels for the Identification of Asymptomatic Patients With Calcific Aortic Valve Disease

(2011) Juan B. Grau et al.   ANNALS OF THORACIC SURGERY

Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease

(2011) Marc S. Sabatine et al.   CIRCULATION

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study

(2010) Panagiota Georgiadou et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis

(2010) Hala Abdel-Hameed Abdel-Azeez et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension—Results from the EUTOPIA trial

(2009) Johan M. Lorenzen et al.   ATHEROSCLEROSIS

The role of osteopontin in inflammatory processes

(2009) Susan Amanda Lund et al.   Journal of Cell Communication and Signaling

Novel Role for Osteopontin in Cardiac Fibrosis

(2008) Peter Zahradka   CIRCULATION RESEARCH

Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart Failure

(2008) Mark Rosenberg et al.   Circulation-Heart Failure